ARTICLES BY SUZANNE HODSDEN

  • Toyota Partners With Segway Inventor Kamen To Develop Stair-Climbing Wheelchairs
    Toyota Partners With Segway Inventor Kamen To Develop Stair-Climbing Wheelchairs

    Toyota announced a strategic partnership with Segway inventor Dean Kamen and his company Deka Research and Development to develop the next-generation iBot, a motorized wheelchair capable of self-balancing and climbing stairs. The deal will give Toyota access to Deka’s proprietary balancing technology while providing Deka with the necessary funds to launch iBot and other potential collaborative projects.

  • Wearable Biosensor That Measures Blood Alcohol In Sweat Wins NIH Prize
    Wearable Biosensor That Measures Blood Alcohol In Sweat Wins NIH Prize

    The National Institute on Alcohol Abuse and Alcoholism (NIAAA), an arm of the National Institute of Health (NIH), has awarded a $200,000 prize to San Francisco-based startup BACtrack for its wristband that monitors blood alcohol concentration (BAC) in sweat. The developers say the device could aid alcoholism research and treatment.

  • Stanford’s New Take On The At-Home Urinalysis Test
    Stanford’s New Take On The At-Home Urinalysis Test

    Stanford University scientists have developed a technology that could make the rapid urine tests frequently used in the doctors’ offices more reliable and accurate for at-home use. By addressing the most common human errors in dipstick testing — timing, volume of sample, and lighting — the technology could deliver faster test results to patients and reduce the burden on overextended medical laboratories and primary care doctors.

  • J&J Growth Plan Includes Over 20 New Hospital And Consumer Medical Devices By 2018
    J&J Growth Plan Includes Over 20 New Hospital And Consumer Medical Devices By 2018

    Johnson & Johnson’s (J&J) medical device business is poised for significant growth across multiple healthcare markets and in several key regions worldwide, according to senior leadership.

  • Medtronic Buys Smith & Nephew’s Gynecology Business For $350M
    Medtronic Buys Smith & Nephew’s Gynecology Business For $350M

    Medtronic has acquired Smith & Nephew’s gynecology business, including a minimally invasive surgical solution, for $350 million. Senior executives from both companies remarked that the acquisition will complement Medtronic’s existing surgical portfolio and grant the business greater innovation opportunities and geographic reach.

  • Siemens Healthineers Expands Into Molecular Cancer Diagnostics
    Siemens Healthineers Expands Into Molecular Cancer Diagnostics

    Siemens Healthineers is broadening its diagnostic portfolio with the acquisition of NEO New Oncology and its next-generation sequencing (NGS) platform. The German startup specializes in the development of both blood-based and tissue-based genomic tests that allow oncologists to better target cancer therapies with less-invasive diagnostics.

  • Apple, Google Ahead In Telemedicine Market; AT&T, Verizon Fighting To Gain Ground
    Apple, Google Ahead In Telemedicine Market; AT&T, Verizon Fighting To Gain Ground

    Tech giants Apple and Google have forged ahead with telemedicine and connected health innovations, while telecom companies Verizon and AT&T have fallen short of their goals to be a part of the U.S. healthcare system’s transformation.

  • Ingestible Origami Robot Unfolds In Stomach
    Ingestible Origami Robot Unfolds In Stomach

    An international team of scientists centered at MIT have further developed a tiny ingestible robot that unfolds from a capsule once swallowed, and could be used to retrieve foreign objects or patch wounds.  New additions to the design include a more biocompatible material and structural modifications that allow the device to be compressed into a swallowable capsule.

  • Cardinal Health Grows Cardiovascular Portfolio, Biosensors International Expands Reach Through Distribution Agreement
    Cardinal Health Grows Cardiovascular Portfolio, Biosensors International Expands Reach Through Distribution Agreement

    Biosensors International has entered into a strategic agreement that will allow Cardinal Health’s subsidiary Cordis to distribute its portfolio of drug-eluting stents (DES).  The partnership will improve Biosensors’ reach in the global cardiovascular market and expand Cordis’ product offering.  

  • GE Healthcare Signs Its First Managed Equipment Service Agreement In the U.S.
    GE Healthcare Signs Its First Managed Equipment Service Agreement In the U.S.

    GE Healthcare has inked a 14-year managed equipment service (MES) agreement to exclusively supply the Heritage Valley Health System (HVHS) with advanced imaging equipment. This deal is the first of its kind GE has signed in the U.S.

More Articles by Suzanne Hodsden

Suzanne Hodsden

Suzanne Hodsden is a contributor who writes regular life sciences news features for several publications. She holds degrees from Denison University and Bowling Green State University.